Global Advanced Wound Care Market To Reach USD 19.32 Billion By 2030, Growing At A CAGR Of 7.6% Marketsandmarketstm
Get PDF Brochure - Market Data & Segmentation:
Key Market Highlights
- Market size, 2025: USD 13.37 billion Market forecast, 2030: USD 19.32 billion Growth rate: CAGR of 7.6% (2025–2030) Key product segment: Dressings Leading wound type segment: Surgical and traumatic wounds Leading end-user segment: Hospitals, ASCs, and wound care centers Leading region: North America Fastest-growing region: Asia Pacific Growth opportunity: Smart bandages with real-time infection monitoring, extended-wear negative pressure wound therapy (NPWT) systems, and advanced wound care solutions for home-based treatment Key players: Solventum (US), Smith+Nephew (UK), Mölnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Integra LifeSciences (US), PAUL HARTMANN AG (Germany), B. Braun SE (Germany), Owens & Minor (US), and Bioventus (US)
Why This Market Matters
The advanced wound care market is expanding as healthcare providers increasingly adopt specialized products to manage chronic, surgical, traumatic, and burn-related wounds. Rising traumatic injuries and accidents, increasing diabetes-related complications, and a growing aging population are driving demand for advanced wound management solutions. These products help accelerate wound healing, reduce infection risks, improve patient outcomes, and support effective treatment across clinical and home care settings. Additionally, innovations such as smart bandages, remote wound monitoring, and advanced NPWT systems are enabling personalized care, improving treatment efficiency, and reducing pressure on hospital capacity.
Market Overview
The advanced wound care market is undergoing significant transformation as hospitals, ambulatory surgery centers (ASCs), wound care centers, and home care providers increasingly adopt advanced wound management products. Dressings, devices and accessories, biological skin substitutes, and topical agents are important components of modern wound care. Increasing surgical volumes, rising chronic disease prevalence, and the growing need to manage non-healing wounds are supporting market growth. However, the high cost of advanced therapies, including bioengineered skin substitutes and antimicrobial dressings, remains a major challenge, particularly in low- and middle-income economies. The development of cost-efficient products and innovative wound monitoring technologies presents opportunities to expand access to advanced wound care.
Analyst Perspective
The advanced wound care industry is moving toward more personalized, technology-enabled treatment approaches that combine advanced dressings, wound management devices, biological products, and remote monitoring capabilities. These solutions are helping healthcare providers improve healing outcomes, reduce infection risks, and support treatment across hospitals and home care settings. Smart bandages with real-time infection monitoring and extended-wear NPWT systems are creating opportunities to improve care delivery and reduce the burden on healthcare facilities. At the same time, the high cost of advanced therapies and shortages of trained wound care specialists remain important challenges. Companies that combine effective wound management technologies, cost-efficient products, and accessible treatment solutions are positioned to benefit from the market's expansion.
Request Sample Pages:
Segment Analysis
By product, the dressings segment accounted for the largest share of the advanced wound care market in 2024. Increasing awareness of advanced wound management, growing adoption across medical facilities, and the rising incidence of hospital-acquired infections are supporting demand for advanced dressings.
By wound type, surgical and traumatic wounds accounted for the largest share of the market in 2024. Growing global surgical volumes, increasing surgical site infections, and the rising incidence of traumatic injuries are driving demand for advanced wound care products that support effective healing and reduce infection risks.
By end user, hospitals, ASCs, and wound care centers represented the largest segment of the market, supported by advanced healthcare infrastructure and higher treatment demand. These facilities increasingly use advanced wound care products to manage complex wounds, improve healing outcomes, and support efficient patient care.
By region, North America accounted for the largest share of the advanced wound care market in 2024, supported by the incidence of chronic wounds and advanced healthcare infrastructure. Asia Pacific is expected to register the highest CAGR through 2030, driven by expanding healthcare infrastructure, increasing healthcare investments, and rising demand for advanced wound management solutions.
Regional Analysis
North America represents the leading regional market for advanced wound care, supported by advanced healthcare infrastructure, the prevalence of chronic wounds, and demand for specialized wound management products. The region's established healthcare facilities and adoption of advanced treatment solutions contribute to market growth.
Asia Pacific represents an important growth opportunity, with expanding healthcare infrastructure, increasing healthcare investments, and rising demand for advanced wound care products. Growing healthcare needs and the adoption of modern wound management technologies are expected to support further market development across the region.
Key Industry Trends
- Increasing demand for advanced dressings to support wound healing and reduce infection risks Rising incidence of traumatic injuries and surgical wounds Growing use of advanced wound care products for chronic and non-healing wounds Increasing adoption of smart bandages and real-time infection monitoring technologies Expanding use of negative pressure wound therapy systems in home care settings Growing demand for cost-efficient advanced wound care solutions Increasing focus on clinical education and workforce training for complex wound management
Competitive Landscape
The competitive landscape of the advanced wound care market includes established medical technology, healthcare product, and wound management companies. Major players include Solventum (US), Smith+Nephew (UK), Mölnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Integra LifeSciences (US), PAUL HARTMANN AG (Germany), B. Braun SE (Germany), Owens & Minor (US), and Bioventus (US).
These companies provide advanced dressings, wound management devices, biological skin substitutes, topical agents, and other specialized wound care solutions. Competition is shaped by product innovation, clinical effectiveness, infection prevention, cost efficiency, and the ability to support wound management across hospitals, wound care centers, and home care settings.
Recent Industry Developments
- Product Launch: April 2024 – Smith+Nephew introduced the RENASYS EDGE system for home-based chronic wound care. Collaboration: March 2025 – Convatec Group PLC and the WOCN Society launched two educational programs to advance clinical training. Expansion: January 2025 – Cardinal Health opened a new distribution center in Texas to scale its At-Home Solutions business. Acquisition: July 2024 – Owens & Minor acquired Rotech Healthcare for USD 1.36 billion, expanding its home care market footprint. Strategic Agreement: July 2024 – Mölnlycke AB strengthened its partnership with MediWound Ltd.
Discover Connected Healthcare Market Opportunities:
Wound Care Market
Wound Dressings Market
Negative Pressure Wound Therapy Market
Bioactive Dressings Market
Burn Care Market

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment